Business

Samsung Biologics Acquires Swiss Company in $1.8 Billion Deal

Updated 2026-07-20 02:25 UTC 1 source Neutral

Samsung Biologics has acquired Switzerland's PolyPeptide Group for $1.8 billion in an all-cash deal, expanding its biopharmaceutical capabilities.

Coverage timeline — 1 article

CNBC

Samsung Biologics acquires PolyPeptide Group for 2.7 trillion won ($1.8 billion)

2026-07-20 02:12 UTC